Michael R. Dobbs, MD, MHCM

Clinical interests

  • Neurology
  • Neurotoxicology
  • Stroke
  • Vascular Neurology

Michael R. Dobbs, MD, MHCM

Biography

My name is Michael Dobbs; I received my medical degree at the University of Kentucky, College of Medicine, Lexington. I am board certified by the American Board of Psychiatry and Neurology in Neurology and Vascular Neurology.

Faculty rank

Professor of Neurology

Education

Degree
University of Kentucky, College of Medicine, Lexington

Residency
University of Kentucky, Lexington

Certifications or Special training
American Board of Psychiatry and Neurology, Neurology
American Board of Psychiatry and Neurology, Vascular Neurology

Neurology

Kentucky Neuroscience Institute

Kentucky Clinic
First Floor, Wing C, Room B101
740 S. Limestone
Lexington KY 40536-0284

Call 859-323-5661
Fax 859-323-3753

Amenities
Dining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs

Kentucky Clinic Map (PDF, 616 KB) »
Directions to Kentucky Clinic Parking »


UK HealthCare accepts many forms of insurance. See list of insurers »

 

Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Grupke S, Hall J, Dobbs M, Bix GJ, Fraser JF.
    Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
    Clin Neurol Neurosurg. 2015 Feb;129:1-9.
  2. Dobbs M, Berger JR.
    Cervical myelopathy secondary to violent tics of Tourette's syndrome.
    Neurology. 2003 Jun 10;60(11):1862-3.
  3. Nath A, Hall E, Tuzova M, Dobbs M, Jons M, Anderson C, Woodward J, Guo Z, Fu W, Kryscio R, Wekstein D, Smith C, Markesbery WR, Mattson MP.
    Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.
    Neuromolecular Med. 2003;3(1):29-39.
  4. Berger JR, Levy RM, Flomenhoft D, Dobbs M.
    Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy.
    Ann Neurol. 1998 Sep;44(3):341-9.

View this provider on PubMed